Inspire Medical Systems, Inc. (INSP) Current Ratio
- Current ratio · latest quarter: Value 8.55×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 8.55× | Current assets / current liabilities. $608.67M ÷ $71.18M ≈ 8.55× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 608.67M USD | Assets, Current |
| Current obligations | 71.18M USD | Liabilities, Current |
| Cash and equivalents | 127.76M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 192.92M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 103.34M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 170.45M USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $608.67M | $71.18M | $127.76M | $192.92M | $103.34M | $170.45M | (m) | (m) | 8.55× |
| 2026-03-31 | $566.82M | $89.42M | $98.93M | $184.90M | $105.09M | $166.24M | (m) | (m) | 6.34× |
| 2025-12-31 | $583.65M | $96.06M | $104.81M | $203.46M | $119.69M | $145.29M | (m) | (m) | 6.08× |
| 2025-09-30 | $586.49M | $110.84M | $112.84M | $209.75M | $107.99M | $141.78M | (m) | (m) | 5.29× |
| 2025-06-30 | $573.19M | $93.36M | $106.93M | $193.97M | $137.69M | $121.63M | (m) | (m) | 6.14× |
| 2025-03-31 | $571.68M | $63.47M | $53.88M | $315.31M | $92.63M | $99.73M | (m) | (m) | 9.01× |
| 2024-12-31 | $630.81M | $88.50M | $150.15M | $295.40M | $93.07M | $80.12M | (m) | (m) | 7.13× |
| 2024-09-30 | $582.52M | $74.26M | $147.51M | $263.48M | $89.74M | $67.43M | (m) | (m) | 7.84× |
| 2024-06-30 | $607.16M | $65.66M | $188.03M | $251.63M | $79.72M | $59.02M | (m) | (m) | 9.25× |
| 2024-03-31 | $572.21M | $72.17M | $175.42M | $265.94M | $72.33M | $48.97M | (m) | (m) | 7.93× |
| 2023-12-31 | $593.74M | $78.11M | $185.54M | $274.84M | $89.88M | $33.88M | (m) | (m) | 7.60× |
| 2023-09-30 | $569.59M | $70.00M | $329.90M | $134.32M | $71.46M | $26.11M | (m) | (m) | 8.14× |
| 2023-06-30 | $560.08M | $66.69M | $467.05M | $0.00 | $63.50M | $20.84M | (m) | (m) | 8.40× |
| 2023-03-31 | $533.58M | $59.87M | $442.13M | $9.93M | $59.77M | $15.66M | (m) | (m) | 8.91× |
| 2022-12-31 | $530.03M | $61.19M | $441.59M | $9.82M | $61.23M | $11.89M | (m) | (m) | 8.66× |
| 2022-09-30 | $495.54M | $49.29M | $417.81M | (m) | $48.50M | $15.15M | (m) | (m) | 10.05× |
| 2022-06-30 | $263.13M | $46.85M | $186.57M | (m) | $40.38M | $21.86M | (m) | (m) | 5.62× |
| 2022-03-31 | $262.48M | $43.17M | $203.29M | (m) | $34.54M | $22.20M | (m) | (m) | 6.08× |
| 2021-12-31 | $268.54M | $41.31M | $214.47M | (m) | $34.18M | $17.23M | (m) | (m) | 6.50× |
| 2021-09-30 | $255.50M | $33.59M | $210.20M | (m) | $26.68M | $15.57M | (m) | (m) | 7.61× |
| 2021-06-30 | $249.49M | $24.35M | $176.54M | (m) | $24.91M | $13.30M | (m) | (m) | 10.25× |
| 2021-03-31 | $260.78M | $19.42M | $182.35M | (m) | $21.65M | $11.38M | (m) | (m) | 13.43× |
| 2020-12-31 | $269.87M | $20.73M | $190.52M | (m) | $25.06M | $8.48M | (m) | (m) | 13.02× |
| 2020-09-30 | $266.92M | $18.20M | $178.71M | (m) | $21.10M | $8.97M | (m) | (m) | 14.67× |
| 2020-06-30 | $267.11M | $13.04M | $211.24M | (m) | $10.23M | $9.97M | (m) | (m) | 20.48× |
| 2020-03-31 | $155.43M | $13.72M | $76.12M | (m) | $11.03M | $7.25M | (m) | (m) | 11.33× |
| 2019-12-31 | $170.64M | $16.86M | $22.86M | (m) | $13.13M | $5.83M | (m) | (m) | 10.12× |
| 2019-09-30 | $170.46M | $12.70M | $48.04M | (m) | $10.98M | $4.67M | (m) | (m) | 13.42× |
| 2019-06-30 | $177.24M | $8.66M | $51.27M | (m) | $9.46M | $3.56M | (m) | (m) | 20.46× |
| 2019-03-31 | $188.54M | $7.83M | $101.94M | (m) | $7.04M | $3.11M | (m) | (m) | 24.09× |
| 2019-01-01 | $199.27M | $11.17M | (m) | (m) | (m) | (m) | (m) | (m) | 17.84× |
| 2018-12-31 | $199.28M | $11.15M | $97.29M | (m) | $6.67M | $2.67M | (m) | (m) | 17.86× |
| 2018-09-30 | $129.96M | $7.59M | $26.31M | (m) | $5.41M | $3.08M | (m) | (m) | 17.11× |
| 2018-06-30 | $133.03M | $9.34M | $121.85M | (m) | $4.49M | $3.55M | (m) | (m) | 14.24× |
| 2018-03-31 | $26.94M | $7.92M | $11.15M | (m) | $3.46M | $3.39M | (m) | (m) | 3.40× |
| 2017-12-31 | $24.10M | $7.15M | $8.96M | (m) | $3.86M | $3.67M | (m) | (m) | 3.37× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |